P/E ratio for EKF Diagnostics (EKF.L)
P/E ratio at the end of 2023: 61.8
According to EKF Diagnostics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 4125.54. At the end of 2023 the company had a P/E ratio of 61.8.
P/E ratio history for EKF Diagnostics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | 61.8 | -355.47% |
| 2022 | -24.2 | -217.6% |
| 2021 | 20.6 | -19.98% |
| 2020 | 25.7 | -37.78% |
| 2019 | 41.3 | 221.92% |
| 2018 | 12.8 | -69.57% |
| 2017 | 42.2 | -100.95% |
| 2016 | < -1000 | 376963.75% |
| 2015 | -1.18 | -89.89% |
| 2014 | -11.7 | -82.03% |
| 2013 | -64.9 | -302.14% |
| 2012 | 32.1 | -331.07% |
| 2011 | -13.9 | 80.76% |
| 2010 | -7.68 | -69.35% |
| 2009 | -25.1 | 1255.81% |
| 2008 | -1.85 | -144.6% |
| 2007 | 4.14 | -45.67% |
| 2006 | 7.63 | 34.99% |
| 2005 | 5.65 | -144.71% |
| 2004 | -12.6 | 86.63% |
| 2003 | -6.77 | -232.47% |
| 2002 | 5.11 | -99.1% |
| 2001 | 566 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.